edaravone has been researched along with Herpes Simplex Virus Infection in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The incidence of facial palsy was assessed following administration of edaravone immediately after HSV-1 inoculation and daily for 11 days thereafter." | 3.79 | Role of nitric oxide in the onset of facial nerve palsy by HSV-1 infection. ( Gyo, K; Hato, N; Kohno, H; Takahashi, H; Yamada, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hato, N | 1 |
| Kohno, H | 1 |
| Yamada, H | 1 |
| Takahashi, H | 1 |
| Gyo, K | 1 |
1 other study available for edaravone and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
Role of nitric oxide in the onset of facial nerve palsy by HSV-1 infection.
Topics: Animals; Antipyrine; Bell Palsy; Biomarkers; Disease Models, Animal; Edaravone; Facial Nerve; Facial | 2013 |